Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25